Irritability: What Could Be Causing It

Why Irritability Is a Medical Symptom, Not a Character Flaw

Persistent irritability is your nervous system signaling that something is off. It may reflect a hormonal deficit, a metabolic imbalance, a sleep disorder, or an undertreated psychiatric condition. The 2013 DSM-5 recognized irritable mood as a valid presentation of major depressive disorder in adults, not just children [1]. This reframing matters clinically.

A 2019 meta-analysis in Psychological Medicine (k = 53 studies, N = 54,632) found that irritability predicted future depression, anxiety, and functional impairment independently of baseline mood [2]. The association held across age groups, genders, and countries. Irritability also appears in the diagnostic criteria for generalized anxiety disorder, PTSD, traumatic brain injury, and several endocrine conditions.

The challenge for clinicians and patients alike is that irritability has no single diagnostic code. ICD-10 lists it under R45.4 ("irritability and anger"), but the symptom itself is shared by conditions spanning every organ system. A structured differential is the only way to avoid both over-psychiatrizing a thyroid problem and under-treating a mood disorder. The sections below walk through the major categories in the order a clinician would typically evaluate them [3].

Hormonal Causes: Thyroid, Testosterone, Estrogen, and Cortisol

Endocrine dysfunction is among the most commonly missed causes of irritability. Start here because these conditions are treatable, testable, and frequently overlooked.

Hyperthyroidism produces irritability in 60-80% of cases, according to data from the American Thyroid Association [4]. Excess thyroid hormone increases adrenergic receptor sensitivity, producing agitation, tremor, and mood lability. A TSH below 0.4 mIU/L with elevated free T4 confirms the diagnosis. Graves' disease, the most common autoimmune cause, affects roughly 1 in 200 people in the United States [4].

Hypothyroidism can also cause irritability, though it more classically presents with fatigue and depressed mood. A 2018 study in the European Thyroid Journal found that 41% of newly diagnosed hypothyroid patients endorsed clinically significant irritability on the Profile of Mood States questionnaire [5].

Low testosterone is a major driver of irritability in men over 40. The Endocrine Society's 2018 clinical practice guideline defines male hypogonadism as a total testosterone below 300 ng/dL drawn before 10 AM, combined with symptoms [6]. A cross-sectional analysis from the European Male Ageing Study (EMAS, N = 3,369) showed that men in the lowest testosterone tertile had 2.1 times the odds of reporting irritable mood compared to the highest tertile [7]. Testosterone replacement therapy (TRT) with testosterone cypionate 100-200 mg weekly has demonstrated mood improvement in randomized trials, including the Testosterone Trials (TTrials, N = 790), where the mood domain showed a statistically significant benefit at 12 months [8].

Perimenopause and estrogen decline represent the most common hormonal cause of irritability in women aged 40-55. The Study of Women's Health Across the Nation (SWAN, N = 3,302) found that women in the menopausal transition had 1.3 to 1.6 times the odds of reporting persistent irritability compared to premenopausal controls, even after adjustment for vasomotor symptoms [9]. Estradiol patches (0.025-0.1 mg/day) have shown efficacy for mood symptoms in multiple RCTs [10].

Cortisol dysregulation rounds out the hormonal category. Both Cushing syndrome (excess cortisol) and adrenal insufficiency (deficient cortisol) can present with irritability, though via different mechanisms. An AM cortisol level and, when indicated, a 24-hour urinary free cortisol or low-dose dexamethasone suppression test can screen for these conditions [3].

Sleep Deprivation and Circadian Disruption

Poor sleep is the single most common modifiable cause of irritability in clinical practice. It deserves its own section because patients frequently minimize it.

A controlled study at the University of Pennsylvania (N = 159) restricted participants to 4, 6, or 8 hours of sleep nightly for 14 consecutive nights. By day 10, the 6-hour group showed cognitive impairment equivalent to 48 hours of total sleep deprivation, and self-reported irritability scores rose 30-40% from baseline in the restricted groups [11]. Dr. Mathew Walker, professor of neuroscience at UC Berkeley, has stated: "The shorter your sleep, the shorter your fuse. The amygdala becomes 60% more reactive to negative emotional stimuli after a night of sleep loss" [12].

Obstructive sleep apnea (OSA) is an underdiagnosed contributor. The Wisconsin Sleep Cohort Study estimated that 80% of moderate-to-severe OSA in middle-aged adults remains undiagnosed [13]. Symptoms include morning headaches, daytime fatigue, and mood disturbance, including irritability. The STOP-BANG questionnaire is a validated screening tool. A score of 3 or higher warrants polysomnography.

Shift work and circadian misalignment produce irritability through melatonin suppression and cortisol phase-shifting. The International Agency for Research on Cancer classifies night shift work as a Group 2A probable carcinogen, but the more immediate clinical effect is mood disruption [14]. Treatment centers on sleep hygiene, timed light exposure, and in select cases, exogenous melatonin 0.5-3 mg taken 2-3 hours before desired sleep onset.

Blood Sugar Instability and Nutritional Deficiencies

Reactive hypoglycemia is the medical term for the agitation, shakiness, and irritability that occur 2-4 hours after a high-glycemic meal. Plasma glucose drops below 70 mg/dL, triggering an adrenergic counter-regulatory response: epinephrine surges, heart rate climbs, and the patient feels intensely irritable. This is physiology, not psychology.

A 2020 study in Psychoneuroendocrinology (N = 107) demonstrated that experimental induction of mild hypoglycemia (glucose ~63 mg/dL) significantly increased self-reported anger and irritability in healthy adults, with the effect more pronounced in participants with higher baseline anxiety [15]. The Endocrine Society recommends evaluation with a mixed-meal tolerance test when reactive hypoglycemia is suspected [16].

Prediabetes and type 2 diabetes also contribute to irritability through glycemic variability. Data from the ACCORD trial (N = 10,251) showed that participants with HbA1c above 8.0% reported worse mood and quality-of-life scores, including irritability domains, compared to those at 6.0-7.0% [17].

Micronutrient deficiencies deserve brief mention. Iron deficiency (ferritin <30 ng/mL even without frank anemia) has been linked to irritability and restless legs in women of reproductive age [18]. Vitamin D levels below 20 ng/mL are associated with mood disturbance in observational studies, though RCT evidence for supplementation improving mood remains mixed [19]. Magnesium deficiency may contribute, though clinical data are limited to small trials.

Psychiatric and Neurological Conditions

Irritability is a diagnostic criterion or recognized feature of at least 12 psychiatric conditions. The most clinically relevant in adults are major depressive disorder (MDD), generalized anxiety disorder (GAD), bipolar disorder, and PTSD.

MDD with irritable mood affects up to 50% of depressed adults, according to a 2017 analysis in Molecular Psychiatry (N = 536,377 from the UK Biobank). Those with irritable depression had earlier onset, more comorbid anxiety, and poorer treatment response to first-line SSRIs compared to those with purely sad depression [20]. The PHQ-9 does not specifically measure irritability, which is why clinicians should supplement screening with direct questioning.

GAD includes irritability as one of six associated symptoms in the DSM-5. A diagnosis requires excessive worry plus three of six symptoms (restlessness, fatigue, concentration difficulty, irritability, muscle tension, sleep disturbance) for at least 6 months [1].

Bipolar II disorder is frequently misdiagnosed as unipolar depression. Hypomanic episodes can present primarily as irritability rather than euphoria. A 2021 review in The Lancet Psychiatry estimated that 40% of bipolar II patients are initially misdiagnosed, with a mean delay to correct diagnosis of 7.5 years [21]. This matters because antidepressant monotherapy can destabilize bipolar disorder.

Traumatic brain injury (TBI) causes irritability in 29-40% of patients, persisting years after injury. Dr. David Arciniegas, professor of psychiatry at the University of Colorado, has noted: "Irritability after TBI is not a personality change; it is a neurological symptom reflecting orbitofrontal and anterior temporal dysfunction that can be treated" [22]. First-line pharmacotherapy includes sertraline 50-200 mg daily or valproate when impulsivity is prominent.

Medications and Substances That Cause Irritability

Drug-induced irritability is common and under-recognized. A systematic review of medication side effects should be part of every irritability workup.

SSRIs and SNRIs can paradoxically cause irritability, particularly in the first 2-4 weeks of treatment or after dose escalation. This is sometimes called "activation syndrome." The effect is more common in younger patients. Fluoxetine and sertraline are the most frequently implicated SSRIs [23].

Corticosteroids such as prednisone at doses above 20 mg/day produce neuropsychiatric effects in approximately 28% of patients, with irritability and insomnia being the most common [24]. Even short courses (5-7 day tapers) can trigger mood changes.

Stimulant medications for ADHD (methylphenidate, amphetamine salts) commonly cause irritability during the wearing-off period. This "rebound irritability" typically occurs 4-6 hours after dosing with immediate-release formulations.

Alcohol withdrawal is an acute and potentially dangerous cause. Irritability begins 6-12 hours after the last drink and peaks at 24-72 hours. The CIWA-Ar scale quantifies withdrawal severity, with scores above 10 indicating moderate withdrawal requiring pharmacotherapy.

Caffeine above 400 mg/day (roughly four 8-ounce cups of brewed coffee) can cause jitteriness, anxiety, and irritability per FDA guidance [25]. Caffeine withdrawal, beginning 12-24 hours after cessation, also causes irritability. This is listed as a diagnosable condition in the DSM-5.

Cannabis withdrawal produces clinically significant irritability in regular users. A meta-analysis in JAMA Psychiatry found that 76% of regular cannabis users who stopped abruptly experienced irritability as the most common withdrawal symptom [26].

The Diagnostic Workup: What to Order and When

A structured approach saves time and reduces diagnostic error. The following two-tier system works well in primary care and telehealth settings.

Tier 1 (order for every patient with persistent irritability lasting more than 2 weeks):

• TSH and free T4
• Fasting glucose and HbA1c
• Total testosterone (men; AM draw before 10 AM)
• Estradiol and FSH (women over 40 with cycle changes)
• CBC with differential
• Comprehensive metabolic panel (CMP)
• Ferritin
• Vitamin D (25-hydroxyvitamin D)
• PHQ-9 and GAD-7 mood screening

Tier 2 (order based on clinical suspicion):

• Free testosterone, SHBG, LH, prolactin (if total testosterone is borderline, 250-350 ng/dL)
• AM cortisol or 24-hour urinary free cortisol (Cushingoid features or chronic fatigue)
• Polysomnography (snoring, apneic episodes, Epworth Sleepiness Scale >10)
• Urine drug screen (when substance use is suspected)
• Brain MRI (new-onset irritability with focal neurological signs, history of TBI)

The PHQ-9 and GAD-7 are free, validated, and take under 5 minutes to complete. A PHQ-9 score of 10 or above has 88% sensitivity and 88% specificity for major depression [27]. If screening suggests bipolar spectrum disorder (mood swings, decreased need for sleep, impulsive behavior), the Mood Disorder Questionnaire (MDQ) is a reasonable next step before referral.

Treatment: Matching the Intervention to the Cause

Effective treatment requires identifying the underlying cause first. Treating irritability symptomatically with benzodiazepines or sedatives without a diagnosis is poor practice and creates dependency risk.

Hormonal correction resolves irritability in the majority of endocrine cases. Levothyroxine normalizes mood in hypothyroid patients within 4-8 weeks of achieving euthyroid TSH. Testosterone replacement in hypogonadal men shows mood benefits in 8-12 weeks. Estradiol therapy in perimenopause can improve irritability within the first cycle of treatment [10].

Sleep optimization is first-line for anyone sleeping fewer than 7 hours. Cognitive behavioral therapy for insomnia (CBT-I) is the recommended first-line treatment per the American College of Physicians. It outperforms sleep medications at 6-month follow-up [28].

Pharmacotherapy for psychiatric causes follows standard guidelines. For MDD with irritability, SSRIs remain first-line, though patients with irritable depression may respond better to SNRIs (venlafaxine 75-225 mg or duloxetine 60-120 mg) based on subgroup analyses from the STAR*D trial [29]. For GAD, buspirone 15-60 mg daily is an alternative that avoids SSRI-induced activation. For bipolar II, mood stabilizers (lamotrigine 100-200 mg or lithium 600-900 mg) are preferred over antidepressant monotherapy.

GLP-1 receptor agonists warrant mention because patients on semaglutide or tirzepatide for weight management sometimes report mood changes. The STEP-1 trial (N = 1,961) did not identify irritability as a statistically significant adverse event, but post-marketing surveillance and the FDA's MedWatch database have received reports [30]. If irritability emerges after starting a GLP-1, evaluate blood sugar patterns and nutritional intake before attributing it to the medication.

Clinicians at HealthRX perform a complete hormone and metabolic panel before prescribing any hormonal therapy. Any patient presenting with persistent irritability receives TSH, free T4, fasting glucose, and an AM testosterone (men) or estradiol/FSH (perimenopausal women) as part of standard intake labs.